News about "Amit Bakshi, chairman and managing director of Eri"

Eris Lifesciences Reports 41% PAT Growth in Q1 FY26, Strengthens Manufacturing and Branded Formulations Portfolio

Eris Lifesciences Reports 41% PAT Growth in Q1 FY26, Strengthens Manufacturing and Branded Formulations Portfolio

Eris Lifesciences Limited, one of India’s leading branded formulations manufacturers, has reported a strong financial and operational performance for the first quarter of FY26. Consolidated revenue grew by 7.4% year-over-year, largely fueled by an 11% rise in its domestic branded formulations business.

Amit Bakshi, Chairman And Managing Director Of Eri | 07/08/2025 | By Darshana 155


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members